Raad I I, Hohn D C, Gilbreath B J, Suleiman N, Hill L A, Bruso P A, Marts K, Mansfield P F, Bodey G P
Department of Medical Specialties, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Infect Control Hosp Epidemiol. 1994 Apr;15(4 Pt 1):231-8.
In many hospitals, the only sterile precautions used during the insertion of a nontunneled central venous catheter are sterile gloves and small sterile drapes. We investigated whether the use of maximal sterile barrier (consisting of mask, cap, sterile gloves, gown, and large drape) would lower the risk of acquiring catheter-related infections.
Prospective randomized trial.
A 500-bed cancer referral center.
We randomized patients to have their nontunneled central catheter inserted under maximal sterile barrier precautions or control precautions (sterile gloves and small drape only). All patients were followed for 3 months postinsertion or until the catheter was removed, whichever came first. Catheter-related infections were diagnosed by quantitative catheter cultures and/or simultaneous quantitative blood cultures.
The 176 patients whose catheters were inserted by using maximal sterile barrier precautions were comparable to the 167 control patients in underlying disease, degree of immuno-suppression, therapeutic interventions, and catheter risk factors for infections (duration and site of catheterization, number of catheter lumen, catheter insertion difficulty, reason for catheter removal). There were a total of four catheter infections in the test group and 12 in the control group (P = 0.03, chi-square test). The catheter-related septicemia rate was 6.3 times higher in the control group (P = 0.06, Fisher's exact test). Most (67%) of the catheter infections in the control group occurred during the first 2 months after insertion, whereas 25% of the catheter infections in the maximal sterile precautions group occurred during the same period (P < 0.01, Fisher's exact test). Cost-benefit analysis showed the use of such precautions to be highly cost-effective.
Maximal sterile barrier precautions during the insertion of nontunneled catheters reduce the risk of catheter infection. This practice is cost-effective and is consistent with the practice of universal precautions during an invasive procedure.
在许多医院,插入非隧道式中心静脉导管时仅采取的无菌预防措施是无菌手套和小无菌巾。我们研究了采用最大无菌屏障(包括口罩、帽子、无菌手套、手术衣和大无菌巾)是否会降低获得导管相关感染的风险。
前瞻性随机试验。
一家拥有500张床位的癌症转诊中心。
我们将患者随机分为两组,一组在最大无菌屏障预防措施下插入非隧道式中心导管,另一组采用对照预防措施(仅无菌手套和小无菌巾)。所有患者在导管插入后随访3个月或直至导管拔除,以先到者为准。通过定量导管培养和/或同步定量血培养诊断导管相关感染。
176例采用最大无菌屏障预防措施插入导管的患者在基础疾病、免疫抑制程度、治疗干预措施以及导管感染危险因素(置管时间和部位、导管腔数量、导管插入难度、拔管原因)方面与167例对照组患者具有可比性。试验组共有4例导管感染,对照组有12例(P = 0.03,卡方检验)。对照组的导管相关败血症发生率高6.3倍(P = 0.06,Fisher精确检验)。对照组大多数(67%)导管感染发生在插入后的前2个月,而最大无菌预防措施组25%的导管感染发生在同一时期(P < 0.01,Fisher精确检验)。成本效益分析表明采用此类预防措施具有很高的成本效益。
插入非隧道式导管时采用最大无菌屏障预防措施可降低导管感染风险。这种做法具有成本效益,并且与侵入性操作中的普遍预防措施相一致。